Evaluation and Statistical Analysis for The Acute-phase Treatment of COVID-19

VernacularTitle:COVID-19学会主導臨床試験における急性期治療に対する臨床評価と統計解析について
Author: Airi TAKAGI ¹ ; Shih-Wei CHIU ¹ ; Takayo SUZUKI ² ; Miyuki ISHIGURO ¹ ; Yuko YAMADA ¹ ; Takuhiro YAMAGUCHI ¹ ; Shin TAKAYAMA ¹
Author Information

1. Clinical Research Data Center, Tohoku University Hospital
2. Division of Biostatistics, Tohoku University Graduate School of Medicine
Keywords: COVID-19; Kampo medicine; clinical trial; observational study; statistical analysis
From:Kampo Medicine 2024;75(3):251-256
CountryJapan
Language:Japanese
Abstract: At the 73rd Academic Conference of the Japan Society for Oriental Medicine held in June 2023, a report on an establishment of evidence for the coronavirus disease-2019 (COVID-19) was presented. As part of this project, we reported how we conducted the observational study and the clinical trial that evaluated the effectiveness of Kampo medicine on the acute symptoms of mild to moderate COVID-19 patients. In this article, we have summarized our experience in these studies from the viewpoint of a statistician, including important things to be considered when writing a research plan and selecting endpoints and statistical analysis methods.